|
Re: Web replay of Yale Presentation from NYC...
|
7
|
Resverlogix Corp.
|
Sep 29, 2015 01:05PM
|
|
NYAS Symposium on Apr 28
|
6
|
Resverlogix Corp.
|
Apr 18, 2016 08:19PM
|
|
Active Sites for Phase 3 Trial
|
6
|
Resverlogix Corp.
|
Feb 18, 2016 07:15PM
|
|
Re: Be careful what you wish for.....short interest and Zenith IPO thoughts.
|
6
|
Resverlogix Corp.
|
Dec 04, 2015 11:22AM
|
|
Re: Resverlogix Announces Annual and Special Meeting of Shareholders
|
6
|
Resverlogix Corp.
|
Oct 07, 2016 10:19AM
|
|
It seems ...
|
6
|
Resverlogix Corp.
|
Nov 09, 2015 12:43PM
|
|
Resverlogix Corp. Selected to Present at Cavendish Global Health Impact Forum
|
6
|
Resverlogix Corp.
|
Oct 22, 2015 08:18AM
|
|
Re: Zenith and Breast Cancer
|
6
|
Zenith Epigenetics
|
Mar 11, 2018 02:36PM
|
|
Resverlogix Commences Phase 3 Clinical Trial BETonMACE With Apabetalone
|
6
|
Resverlogix Corp.
|
Oct 26, 2015 07:28AM
|
|
FDA halts use of antibody drugs that don't work vs. omicron
|
6
|
Resverlogix Corp.
|
Jan 24, 2022 06:41PM
|
|
Re: When in Rome.......ESC presentations from August now online
|
6
|
Resverlogix Corp.
|
Sep 26, 2016 09:36AM
|
|
A bit dated but still relevant article
|
6
|
Zenith Epigenetics
|
Jun 15, 2018 07:19PM
|
|
Don on CTV Calgary News 6:18pm
|
6
|
Resverlogix Corp.
|
Jan 24, 2022 08:24PM
|
|
Re: Resverlogix and Zenith AGMs
|
6
|
Resverlogix Corp.
|
Aug 23, 2016 10:38AM
|
|
Awaken Dormant DNA, Epigenetically - Article in GEN
|
6
|
Zenith Epigenetics
|
Jan 12, 2018 06:03PM
|
|
New docs on SEDAR
|
6
|
Zenith Epigenetics
|
Jan 01, 2016 10:27AM
|
|
Clovis' Rubracra
|
6
|
Zenith Epigenetics
|
Oct 03, 2018 01:02PM
|
|
Nice background article on mCRPC
|
5
|
Zenith Epigenetics
|
Oct 02, 2016 08:29PM
|
|
Re: Richmond Club presentation
|
5
|
Resverlogix Corp.
|
Mar 30, 2016 03:12PM
|
|
BET Inhibitors may help Overcome a Newly Recognized Form of Resistance to Prostate Cancer Drugs
|
5
|
Zenith Epigenetics
|
Jun 22, 2021 09:34AM
|
